354 related articles for article (PubMed ID: 16983521)
21. A one year health economic model comparing transdermal fentanyl with sustained-release morphine in the treatment of chronic noncancer pain.
Frei A; Andersen S; Hole P; Jensen NH
J Pain Palliat Care Pharmacother; 2003; 17(2):5-26. PubMed ID: 14649386
[TBL] [Abstract][Full Text] [Related]
22. [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].
Zhen ZJ; Sun XF; Xia Y; Ling JY; Zheng L; Luo WB; Lin H
Ai Zheng; 2007 Aug; 26(8):866-9. PubMed ID: 17697549
[TBL] [Abstract][Full Text] [Related]
23. Predictors of long-acting opioid use and oral versus transdermal route among older Medicaid beneficiaries.
Rigler SK; Shireman TI; Kallenbach L
Am J Geriatr Pharmacother; 2007 Jun; 5(2):91-9. PubMed ID: 17719511
[TBL] [Abstract][Full Text] [Related]
24. Assessment of dosing frequency of sustained-release opioid preparations in patients with chronic nonmalignant pain.
Gallagher RM; Welz-Bosna M; Gammaitoni A
Pain Med; 2007; 8(1):71-4. PubMed ID: 17244106
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of opioids in the treatment of chronic non-cancer pain.
Trescot AM; Glaser SE; Hansen H; Benyamin R; Patel S; Manchikanti L
Pain Physician; 2008 Mar; 11(2 Suppl):S181-200. PubMed ID: 18443639
[TBL] [Abstract][Full Text] [Related]
26. Transdermal buprenorphine in cancer pain and palliative care.
Sittl R
Palliat Med; 2006; 20 Suppl 1():s25-30. PubMed ID: 16764218
[TBL] [Abstract][Full Text] [Related]
27. Are there cost benefits to fentanyl for breakthrough pain?
Davis MP
J Pain Symptom Manage; 2012 Sep; 44(3):e1-2. PubMed ID: 22939453
[No Abstract] [Full Text] [Related]
28. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
29. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
[TBL] [Abstract][Full Text] [Related]
30. Economic evaluation of OROS hydromorphone for chronic pain: a Pan-European perspective.
Hauber AB; Fleischmann J; Lothgren M; Wilson M; Lam A; Dubois D; Sabatowski R
J Opioid Manag; 2011; 7(4):287-96. PubMed ID: 21957828
[TBL] [Abstract][Full Text] [Related]
31. [Morphine or oxycodone tablets for pain?].
Fredheim OM; Dale O; Kaasa S; Borchgrevink PC
Tidsskr Nor Laegeforen; 2010 Aug; 130(15):1479-81. PubMed ID: 20706310
[TBL] [Abstract][Full Text] [Related]
32. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain.
Allan L; Hays H; Jensen NH; de Waroux BL; Bolt M; Donald R; Kalso E
BMJ; 2001 May; 322(7295):1154-8. PubMed ID: 11348910
[TBL] [Abstract][Full Text] [Related]
33. Switching from transdermal drugs: an observational "N of 1" study of fentanyl and buprenorphine.
Mercadante S; Porzio G; Fulfaro F; Aielli F; Verna L; Ficorella C; Casuccio A; Riina S; Intravaia G; Mangione S
J Pain Symptom Manage; 2007 Nov; 34(5):532-8. PubMed ID: 17629666
[TBL] [Abstract][Full Text] [Related]
34. [Transdermal fentanyl in treating severe painful mucositis caused by autologous hematopoietic stem cell transplantation].
Huang HQ; Cai QQ; Lin XB; Wang BF; Bu Q; Gao Y; Peng YL
Ai Zheng; 2007 Apr; 26(4):390-3. PubMed ID: 17430658
[TBL] [Abstract][Full Text] [Related]
35. National utilization of transdermal fentanyl among community-dwelling older people in Finland.
Bell JS; Klaukka T; Ahonen J; Hartikainen S
Am J Geriatr Pharmacother; 2009 Dec; 7(6):355-61. PubMed ID: 20129256
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain.
Kwong WJ; Ozer-Stillman I; Miller JD; Haber NA; Russell MW; Kavanagh S
Clin Ther; 2010 Sep; 32(10):1768-81. PubMed ID: 21194601
[TBL] [Abstract][Full Text] [Related]
37. Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee.
Marshall DA; Strauss ME; Pericak D; Buitendyk M; Codding C; Torrance GW
Am J Manag Care; 2006 Apr; 12(4):205-14. PubMed ID: 16610922
[TBL] [Abstract][Full Text] [Related]
38. A research-based guideline for appropriate use of transdermal fentanyl to treat chronic pain.
Wakefield B; Johnson JA; Kron-Chalupa J; Paulsen L
Oncol Nurs Forum; 1998 Oct; 25(9):1505-13. PubMed ID: 9802048
[TBL] [Abstract][Full Text] [Related]
39. [Transdermal fentanyl].
Lossignol D; Sternon J
Rev Med Brux; 1998 Apr; 19(2):83-6. PubMed ID: 9643088
[TBL] [Abstract][Full Text] [Related]
40. [Driving ability under opioids: current assessment of published studies].
Sabatowski R
Dtsch Med Wochenschr; 2008 Jun; 133 Suppl 2():S25-8. PubMed ID: 18548365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
